An update from Guardant Health (GH) is now available.
Guardant Health, Inc. has amended its compensation agreement with its co-CEOs, maintaining their symbolic annual base salary of $1 and changing their incentives structure. Starting in 2024, instead of a base salary and annual cash bonus, each co-CEO will receive $800,000 in restricted stock units (RSUs) and performance-based RSUs (PSUs) annually, with specific vesting conditions tied to company performance goals. Additionally, they will each receive long-term awards of RSUs and PSUs valued at $5 million, with a vesting schedule that extends into 2025 and is contingent on achieving certain revenue and shareholder return targets. Previous awards from 2020 were cancelled as part of this new arrangement.
Find detailed analytics on GH stock on TipRanks’ Stock Analysis page.
